Arthritis & Rheumatism

Obstructive sleep apnea linked with higher risk of gout

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis ...

Cardiology

Gout could increase heart disease risk

Having a type of inflammatory arthritis called gout may worsen heart-related outcomes for people being treated for coronary artery disease, according to new research.

Diseases, Conditions, Syndromes

Gout not associated with increased risk of fracture, study finds

Gout, a painful inflammatory arthritis, is not associated with an increased risk of fracture, according to a large study led by Keele University, and published in CMAJ (Canadian Medical Association Journal).

Immunology

Tiny fish leading the way in a cure for gout

A popular aquarium fish that grows no longer than 4 cm could provide the breakthrough in treating and preventing extremely painful attacks of joint inflammation that are a key concern to patients with gout.

Diseases, Conditions, Syndromes

Major cardiovascular study of gout patients has unexpected finding

A large study of cardiovascular events in gout patients taking one of two medications to prevent excess build-up of uric acid has found that one of the drugs, febuxostat, increased the risk of death for those with heart disease, ...

Oncology & Cancer

Allopurinol Rx more likely with eligibility at diagnosis

(HealthDay)—Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.

Immunology

The role of monosodium urate crystals in gout

An attack of gout is said to be like your joint catching fire, and someone slamming it with a hammer to put out the flames. Now A*STAR researchers have identified how the build-up of monosodium urate (MSU) crystals in the ...

Arthritis & Rheumatism

Drug combination benefits patients with tophaceous gout

The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients ...

page 5 from 12